This article has Open Peer Review reports available.
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways
- Kengo Shimazu†1, 2, 3,
- Yuji Tada†1,
- Takao Morinaga2,
- Masato Shingyoji4,
- Ikuo Sekine5,
- Hideaki Shimada6,
- Kenzo Hiroshima7,
- Takao Namiki3,
- Koichiro Tatsumi1 and
- Masatoshi Tagawa2, 8Email author
© The Author(s). 2017
Received: 20 August 2016
Accepted: 25 April 2017
Published: 2 May 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|20 Aug 2016||Submitted||Original manuscript|
|1 Sep 2016||Author responded||Author comments - Masatoshi Tagawa|
|Resubmission - Version 2|
|1 Sep 2016||Submitted||Manuscript version 2|
|21 Nov 2016||Reviewed||Reviewer Report - Carlos J. Ciudad|
|9 Feb 2017||Reviewed||Reviewer Report - Frances Lennon|
|11 Mar 2017||Author responded||Author comments - Masatoshi Tagawa|
|Resubmission - Version 3|
|11 Mar 2017||Submitted||Manuscript version 3|
|12 Apr 2017||Author responded||Author comments - Kengo Shimazu|
|Resubmission - Version 4|
|12 Apr 2017||Submitted||Manuscript version 4|
|18 Apr 2017||Author responded||Author comments - Kengo Shimazu|
|Resubmission - Version 5|
|18 Apr 2017||Submitted||Manuscript version 5|
|25 Apr 2017||Editorially accepted|
|2 May 2017||Article published||10.1186/s12885-017-3300-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.